All 11 clinically significant isolates of Branhamella catarrhalis examined in this study were found to produce f8-lactamase. The 
Branhamella (Neisseria) catarrhalis, previously considered a harmless, upper respiratory tract commensal of humans (9) , is now recognized as the etiological agent of significant disease in humans. It has been implicated in a wide variety of infectious processes (G. V. Doern, M. J. Miller, R. E. Winn, submitted for publication), including conjunctivitis, otitis media, sinusitis, endocarditis, meningitis, septicemia, and pneumonia, particularly in patients with underlying compromised pulmonary function. Although previously defined as being uniformly susceptible to penicillin (5) , several recent studies demonstrated that clinically significant isolates of B. catarrhalis were resistant to penicillin by virtue of their ability to produce /3-lactamase (8, 10, (12) (13) (14) . Due to the paucity of reported clinical antibiotic trials and in vitro susceptibility studies, little additional information exists regarding the antimicrobial susceptibility of B. catarrhalis. The present study was undertaken in an attempt to define the nature of the ,B-lactamase produced by B. catarrhalis and to elucidate the antimicrobial susceptibility pattern of this organism. 
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MATERIALS AND METHODS Organisms. The 11 clinically significant isolates of B. catarrhalis and other organisms employed in this study are described in Table 1. ,a-Lactamase determinations. /3-Lactamase production was determined by the iodometric penicillinagar overlay method of Baldwin et al. (1) with organisms grown on GC agar (Difco) with or without 1 jAg of penicillin G per ml for 16 h at 37°C in 10% CO, and by the rapid acidometric tube method of Escamilla (6) with organisms grown on IsoVitaleX-enriched (BBL Microbiology Systems) chocolate agar for 16 h at 35°C in 10% CO2. A 10-mg/mil solution of penicillin G (GIBCO Laboratories, Grand Island, N.Y.) was used as a substrate in the iodometric penicillin-agar overlay method. A 120-mg/ml solution of penicillin G (Pfizer Inc.) was used as a substrate in the rapid acidometric tube method.
Isolation of plasmid DNA. Cultures of B. catarrhalis and N. gonorrhoeae were grown to a density of 10' colony-forming units per ml in glucose-containing liquid medium as previously described (11) . To prevent the loss of plasmids, penicillin G (1 ,ug/ml) was added to all medium used to grow fl-lactamase-producing strains.
Two independent isolation procedures were used to purify supercoiled plasmid deoxyribonucleic acid (DNA). The first procedure was essentially as described by Baron et al. (2) . In the second technique, a modification of the Hirt lysis procedure was employed (7) . The cells were concentrated 50-to 100-fold by (14) . In contra-0.4, and 0.4 jLg/ml, respectively. distinction to the f3-lactamase of N. gonorrhoeae Finally, it should be emphasized that the B. (4, 8) , our data suggest that the fl-lactamase of catarrhalis ATCC 8176 is significantly different B. catarrhalis possesses minimal or no cepha-from the strains of B. catarrhalis described in losporinase activity. If this is so, then fl-lacta-this study which were associated with human mase inhibitors such as clavulanic acid and CP disease.! As previously reported (G. V. Doern 45899 would depress the penicillinase-sensitive and S. A. Morse, submitted for publication), penicillin MICs, but would not affect the MICs ATCC 8176 possessed several growth characterof the penicillinase-resistant penicillins, cepha-istics (growth on nutrient agar at 22°C and ablosporins, or cephamycin. Indeed, both clavu-sence of growth on Thayer-Martin medium) diflanic acid and CP 45899 markedly lowered pen-ferent from those of numerous clinically signifiicillin and ampicillin MICs 
